Aug 4 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab on Tuesday reported a 12.1% increase in first-quarter profit, driven by strong demand for generic drugs in ‌its key U.S.

BEDMINSTER, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC announces the U.S. availability of Ciprofloxacin Otic Solution 0.2%, an FDA-approved, AB-rated, quinolone antimicrobial ...

India's Alembic Pharma posts quarterly profit rise on strong generics demand India's Alembic Pharmaceuticals on Tuesday reported a 12.1% increase in first-quarter profit, driven by strong demand for ...

Ownership Discover who owns Alembic Pharmaceuticals Ltd. Access the ownership overview, view the top Alembic Pharmaceuticals Ltd shareholders, institutional holders, and leading mutual fund investors.

Generic drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for Prucalopride Tablets, 1 mg and 2 mg, ...